McLaren A J, Marshall S E, Haldar N A, Mullighan C G, Fuggle S V, Morris P J, Welsh K I
Nuffield Department of Surgery, John Radcliffe Hospital, Oxford, England, United Kingdom.
Kidney Int. 1999 May;55(5):1977-82. doi: 10.1046/j.1523-1755.1999.00427.x.
Chronic allograft failure (CAF) is a major cause of late graft loss in renal transplantation. Up-regulation of adhesion molecules has been demonstrated in renal allograft biopsies during both acute and chronic rejection, and these molecules are known to regulate leukocyte migration into the graft.
A single-center retrospective study was performed between 1985 and 1996 on renal transplant recipients who developed CAF. Genotyping was performed for five polymorphisms in intercellular adhesion molecule-1 (ICAM-1), E-selectin, and L-selectin. Frequency data for the polymorphisms in the CAF group (N = 62) and their matched donors, where available (N = 33), were compared with a group of recipients with graft survival of more than 10 years (N = 110) and a group of United Kingdom (UK) controls (N = 101).
A variant allele in exon 4 of ICAM-1 (R241) was more common in the CAF recipients compared with both long-term survivors and UK controls (19.4 vs. 10.0 and 9.4%, P = 0.015 and 0.025). In addition, stratification by time to graft failure caused by CAF revealed more rapid failure in the presence of another ICAM-1 variant in the recipient (E469) in exon 6 (P = 0.033).
ICAM-1 polymorphisms may represent a predetermined genetic risk factor for CAF. The polymorphism in exon 4 is in the Mac-1 binding site, and that in exon 6 is in the fifth immunoglobulin-like domain. Potential mechanisms of action of ICAM-1 variants in CAF include an alteration of activity as an adhesion molecule, altered costimulation, or a minor histocompatibility antigen.
慢性移植肾失功(CAF)是肾移植后期移植肾丢失的主要原因。在急性和慢性排斥反应期间,肾移植活检已证实黏附分子上调,并且已知这些分子可调节白细胞向移植物内的迁移。
1985年至1996年对发生CAF的肾移植受者进行了一项单中心回顾性研究。对细胞间黏附分子-1(ICAM-1)、E-选择素和L-选择素的5种多态性进行基因分型。将CAF组(N = 62)及其匹配供体(如有,N = 33)的多态性频率数据与移植肾存活超过10年的受者组(N = 110)和一组英国对照(N = 101)进行比较。
与长期存活者和英国对照相比,ICAM-1第4外显子(R241)中的一个变异等位基因在CAF受者中更为常见(19.4%对10.0%和9.4%,P = 0.015和0.025)。此外,按CAF导致的移植肾失功时间分层显示,受者第6外显子中存在另一种ICAM-1变异(E469)时移植肾失功更快(P = 0.033)。
ICAM-1多态性可能是CAF的一个预先确定的遗传危险因素。第4外显子中的多态性位于Mac-1结合位点,第6外显子中的多态性位于第5个免疫球蛋白样结构域。ICAM-1变异在CAF中的潜在作用机制包括作为黏附分子的活性改变、共刺激改变或次要组织相容性抗原。